|Bid||0.00 x 1200|
|Ask||0.00 x 1100|
|Day's Range||26.00 - 26.42|
|52 Week Range||21.24 - 33.00|
|Beta (5Y Monthly)||0.70|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 26, 2022 - May 02, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||31.78|
The Nasdaq exchange issues a notice to DENTSPLY SIRONA (XRAY) for filing delinquency from the exchange and for non-compliance with the Nasdaq Listing Rules. Shares fall.
For the all the working parents at Alkermes, we recognize that there is no greater responsibility than being present for your family. That’s why we’re so proud to be listed as one of The Best Place...
FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) Lynparza as a combination therapy for patients with metastatic castration-resistant prostate cancer.